Publications by authors named "Timothy Keen"

Claim this Profile
P
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.
Shixia Wang, Ranajit Pal, John R Mascola, Te-Hui W Chou, Innocent Mboudjeka, Timothy Keen

Virology· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype.
Ranajit Pal, V S Kalyanaraman, B C Nair, Stephen Whitney, Timothy Keen

Virology· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitive toxicology and biodistribution study of a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 (HIV-1) vaccine in rabbits.
Ranajit Pal, Qiao Yu, Shixia Wang, V S Kalyanaraman, B C Nair, Timothy Keen

Vaccine· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate.
Ranajit Pal, Shixia Wang, V S Kalyanaraman, B C Nair, Stephen Whitney, Timothy Keen

J Med Primatol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis